Gallman Cari bought BMY

August 1, 2025 · Form 4 insider transaction

Gallman Cari bought 1,061 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction

Acquired (buy-side)

1,061

Price

$0.00

Total value

N/A

InsiderGallman Cari

Role—

CompanyBristol-Myers Squibb Company (BMY)

SecurityCommon Stock, $0.10 par value

Transaction codeM — Option exercise

Transaction dateAugust 1, 2025

Filing dateAugust 5, 2025

Shares owned after9,383

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

These restricted stock units vest in three equal installments beginning on August 1, 2024.

View the original Form 4 on SEC EDGAR